Strathspey Crown acquired Evolus, giving its subsidiary Alphaeon Corporation the exclusive license to market the neurotoxin developed by Daewoon Pharmaceutical.
Strathspey Crown Holdings
- Investor Dan Calugar Discusses Whether the Emergence of Quantum Computing in Algorithmic Trading Is a Game-Changer for Financial Markets
- Meet Grant Conner: The Eco-Friendly Gold Supplier Revolutionizing the Jewelry Industry
- MBD Financials: The Revolutionary Platform Redefining How We Harness the Digital Age to Empower Others